Share Price:

APNASPENAspen Pharmacare Hldgs147780 (0.00%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Building a More Resilient Healthcare Future: Insights from Aspen’s Dr Stavros Nicolaou

Aspen’s Group Senior Executive: Strategic Trade, Dr Stavros Nicolaou, was recently featured on Reality Check, a regular segment on SAfm’s The National Briefing, hosted by Cathy Mohlahlana.
building-a-more-resilient-healthcare-future-insights-from-aspens-stavros-nicolaou-group-senior-executive-800x800

The series provides in-depth analysis and expert perspectives on some of the key social, economic and policy issues shaping South Africa.

Across several discussions, Dr Nicolaou shared insights on critical healthcare and pharmaceutical industry topics.

These conversations highlight the importance of collaboration between government, industry and broader society in building a healthcare system that is more resilient, inclusive and prepared for the future.

Take a look at the five episodes below:

Facebook
Twitter
LinkedIn

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: